Assessment of β Cell Mass and Function by AIRmax and Intravenous Glucose in High-Risk Subjects for Type 1 Diabetes

Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance

(2016) Saba Sheikh et al.   DIABETES

β-cell Mass in Nondiabetic Autoantibody-Positive Subjects: An Analysis Based on the Network for Pancreatic Organ Donors Database

(2016) Marc Diedisheim et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association

(2015) Richard A. Insel et al.   DIABETES CARE

Islet Transplantation for Type 1 Diabetes, 2015: What Have We Learned From Alloislet and Autoislet Successes?

(2015) R. Paul Robertson   DIABETES CARE

Reduced β-cell function in early preclinical type 1 diabetes

(2015) Maarit K Koskinen et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Arginine is preferred to glucagon for stimulation testing of β-cell function

(2014) R. Paul Robertson et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Assessment of β-Cell Mass and α- and β-Cell Survival and Function by Arginine Stimulation in Human Autologous Islet Recipients

(2014) R. Paul Robertson et al.   DIABETES

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

(2008) Jeffrey L Mahon et al.   PEDIATRIC DIABETES